Villanueva, Kris Ashly G.
HRN: 13-93-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/21/2024
03/27/2024
PO
8ml
BID
PCAP B
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes